WIR BEHANDELN ANDERE SO,
WIE WIR SELBST
BEHANDELT WERDEN MÖCHTEN

O. UNIV. PROF. DR. WOLFGANG GSTÖTTNER

Person

Wissenschaft

Originalarbeiten 04/2009

1. Burian M, Gstoettner W Vestibulo-cochleäre Anastomose im Hirnstamm des Meerschweinchens. Vorläufiger Bericht.

Laryng Rhinol Otol 66:404-5, 1987

Impact factor: 0,493

2. Gstoettner W, Burian M Vestibular nuclear complex in the guinea pig: A cytoarchitectonic study and map in three planes.

J Comp Neurol 257:176-88, 198
Impact factor: 3,772

3. Burian M, Gstoettner W Projection of primary vestibular afferent fibers to the cochlear nucleus in the guinea pig.

Neuroscience Letters: 84:13-7, 1988
Impact factor: 4,626

4. Burian M, Gstoettner W, Zundritsch R Saccular afferent fibers to the cochlear nucleus in the guinea pig.

Europ Arch Otorhinolaryngol 246:238-41, 1989
Impact factor: 0,646

5. Burian M, Gstoettner W, Mayr R Brainstem projection of the vestibular nerve in the guinea pig: An HRP (horseradish peroxidase) and WGA-HRP (wheatgerm agglutinin-HRP) study.

J Comp Neurol. 293:165-77, 1990
Impact factor: 3,772

6. Neuwirth-Riedl K, Burian M, Nekahm D, Gstoettner W Optimizing of electroneuronography of the facial nerve.

ORL 52:360-7, 1990
Impact factor: 0,734

7. Gstoettner W, Burian M, Zundritsch R, Mayr R The origin of the vestibulo-cochlear projection in the guinea pig.

Neuroscience Letters 122:163-6, 1991
Impact factor: 4,626

8. Burian M, Cartellieri M, Wutschitz Ch, Gstoettner W Saccular afferents to second order cochlear neurons: An horseradish peroxidase (HRP) and immuncytochemical study.

Europ Arch Otorhinolaryngol 248:432-5, 1991
Impact factor: 0,646

9. Gstoettner W, Burian M, Cartellieri M Central projections from singular parts of the vestibular labyrinth in the guinea pig.

Acta Otolaryngol 112:486-95, 1992
Impact factor: 0,812

10. Gstoettner W, Neuwirth-Riedl K, Swoboda H, Mostbeck W , Burian M Specificity of auditory brainstem response audiometry criteria in acoustic neuroma screening as function of deviation of refernce values in patients with cochlear hearing loss.

European Arch Otorhinolaryngol 249:253-6, 1992
Impact factor: 0,646

11. Gstoettner W., Steurer M., Baumgartner W., Neuwirth-Riedel K Sprachverständlichkeitsmessungen mit dem modifizierten Sotscheck-Test.

Oto Rhino Laryngol Nova 2:258-61, 1992
Impact factor: 0,083

12. Gstoettner W, Steurer M, Baumgartner W Analyse von Phonemverwechslungen unter Störgeräuscheinfluss.

Oto Rhino Laryngol Nova 2:302-5, 1992
Impact factor: 0,083

13. Gstoettner W, Swoboda H, Müller Ch, Burian M Preclinical detection of initial vestibulocochlear abnormalities in a patient with multiple sclerosis.

European Arch Otorhinolaryngol 250:40-3, 1993
Impact factor: 0,646

14. Steurer M, Baumgartner W, Gstoettner W Sprachverständlichkeitsmessung im Rauschen mit Hilfe der Transinformationsanalyse.

Oto Rhino Laryngol Nova 3:317-322,
1993 Impact factor: 0,083

15. Kornfehl J, Gstoettner W, Kontrus W, Sedivy A Transpalatine excision of a cavernous hemangioma of the infratemporal fossa.

Eur Arch Otorhinolaryngol 253;172-175. 1996
Impact factor: 0,646

16. Gstoettner W, Baumgartner WD, Hamzavi J, Felix F, Svozil K, Meyer R, Ehrenberger K Auditory fractal random signals: Experimental data and clinical application.

Acta Otolaryngol 116:222-223, 1996
Impact factor: 0,812

17. Kiefer J, Müller J, Pfennigdorf T, Schön F, Ilberg C, Baumgartner W, Gstoettner W, Ehrenberger K, Arnold W, Stephan K, Thumfart W, Baur S Speech understanding in quiet and noise with the CIS speech coding strategy ( Med El Combi 40) compared to the Mpeak and Speak- strategies (Nucleus).

ORL 58:127-35, 1996
Impact factor: 0,734

18. Gstoettner WK, Baumgartner WD, Franz P, Hamzavi J The implantation of the Combi 40 Cochlear implant.

Central and East Europ J ORL, Head and Neck Surg 1:214-8, 1996

19. Helms J, Mueller J, Schoen F, Winkler F, Moser L, Gstoettner w, et al Comparison of the TEMPO+ Ear-Level Speech Processor and the CIS PRO+ Body-Worn Processor in Adult MED-EL Cochlear Implant Users

ORL 58:127-35, 1996
Impact factor: 0,734

20. Gstoettner W, Baumgartner WD, Franz P, Hamzavi J Cochlear implant deep-insertion surgery.

Laryngoscope, 107:544-6, 1997
Impact factor: 1,457

21. Gstoettner W, Plenk H, Franz P, Hamzavi J, Baumgartner W, Czerny C, Ehrenberger K Cochlear implant deep electrode insertion: Extent of insertional trauma.

Acta Otolaryngol 117:274-7, 1997
Impact factor: 0,812

22. Gstoettner WK, Baumgartner WD, Hamzavi JS, Franz P Erste Erfahrungen mit dem Combi 40 Cochlear - Implantat: Chirurgische Aspekte.

HNO 45: 17-21, 1997
Impact factor: 0,722

23. Gstoettner WK, Baumgartner W, Hamzavi J, Franz P Surgical Experience with the Combi 40 Cochlear implant.

Adv Otorhinolaryngol 52:143-6, 1997

24. Gstoettner W, Hamzavi C, Czerny C Rehabilitation Hörgeschädigter mit Cochlear Implantaten

Der Radiologe 37: 991-4, 1997
Impact factor: 0,621

25. Gstoettner W Cochleoscopy

HNO 45 (4):179-0, 1997
Impact factor: 0,722

26.Baumgartner W, Franz P, Gstoettner W, Hamzavi J Cochlea endoscopy in vivo.

Adv Otorhinolaryngol 52:62-5, 1997

27. Kiefer J, Müller J, Pfennigdorff T, Schön F, Helms J, von Ilberg C, Baumgartner W, Gstoettner W,Ehrenberger K, Arnold W, Stephan K, Thumfart W, Baur S Speech understanding in quiet and noise with the CIS-speech coding strategy (Med-El-Combi 40) compared to the MPEAK and SPEAK strategies (Nucleus).

Adv Otorhinolaryngol 52:286-90, 1997

28. Helms J, Müller J, Schön F, Moser L, Arnold W, Janssen T, Ramsden R, von Ilberg C, Kiefer J, Pfennigdorf T, Gstoettner W, Ehrenberger K, Baumgartner W et al. Evaluation of performance with the Combi 40 cochlear implant in adults: A multicentric clinical study.

ORL 59:23-35, 1997
Impact factor: 0,734

29. Czerny C, Trattnig S, Baumgartner WD, Gstoettner W, Imhof H MRI of the regions of the inner ear and cerebellopontine angle using a 3D T2-weighted turbo spin-echo sequence. Comparison with conventional 2D T2-weighted turbo spin-echo sequences and T1-weighted spin-echo sequences.

Röntgenfortschritte 167:377-83, 1997
Impact factor: 0,582

30. Czerny C, Steiner E, Gstoettner W, Baumgartner WD, Imhof H Postoperative radiographic assessment of the Combi 40 Cochlear Implant.

AJR (American Journal of Roentgenology) 169:1689-94, 1997
Impact factor: 2,351

31. Brill SM, Gstoettner W, Helms J, von Ilberg C, Baumgartner W, Müller J, Kiefer J Optimization of channnel number and stimulating rate for the fast continous interleaved sampling strategy in the Combi 40+.

Am J of Otology 18:104-106, 1997
Impact factor: 1,199

32. Brockmeier S J, Baumgartner W D, Steinhoff J, Nopp P, Weisser P, Thurner E, Ebenhoch H, Gedlicka W, Arnold W, Gstoettner W Influence of the Band-Pass Filter Configuration on Speech Perception and Patient Preference in the Combi-40+ Cochlear Implants

Adv Otorhinolaryngol 52:286-90, 1997

33. Muhm M, Polterauer P, Gstoettner W, Temmel A, Richling B, Undt G, Niederle B, Staudacher M, Ehringer H Diagnostic and therapeutic approaches to carotid body tumors: Review of 24 patients

Arch Surg 132:279-284, 1997
Impact factor: 2,792

34. Formanek M, Czerny C, Gstoettner W, Kornfehl J Cochlear implantation as a successful rehabilitation for radiation-induced deafness

Eur Arch Otorhinolaryngol 255:175-8, 1998
Impact factor: 0,646

35. Schickinger B, Gstoettner W, Czerny C, Kornfehl J Variant petrotympanic fissure as possible cause of an otologic complication during TMJ arthroscopy

Int J Oral Maxillofac Surg. 27:17-19, 1998
Impact factor: 0,972

36. Gstoettner W, Hamzavi J, Aloy A, Kornfehl J Die funktionserhaltende chirurgische Therapie von Kopf – Hals – Tumoren mit dem CO2 Laser

Der Radiologe 38:106-108, 1998
Impact factor: 0,621

37. Youssefzadeh S, Baumgartner W, Dorffner R, Gstoettner W, Trattnig S MR Compatibility of Med El Cochlear implants: Clinical testing at 1.0 T.

Journal of Computer AssistedTomography 22:346-350, 1998
Impact factor: 1,561

38. Helms J., Müller J, Schön F, Moser L, Arnold W, Janssen T, Ramsden R, von. Ilberg C, Kiefer J, Pfennigdorf T, Gstoettner W, K Ehrenberger, W.Baumgartner et al. Evaluation of performance with the Combi 40 cochlear implant in adults: A multicentric clinical study.

Central and East Europ J ORL, Head and Neck Surg 3:159-173, 1998

39. Czerny C, Rand T, Gstoettner W, Woelfl G, Imhof H, Trattnig S MR imaging of the innen ear and the cerebellopontine angle: Comparison of three dimensional and two dimensional Sequences.

AJR (American Journal of Roentgenology) 170:791-796, 1998
Impact factor: 2,351

40. Gstoettner W, Hamzavi J, Baumgartner W Speech discrimination scores of postlingually deaf adults implanted with the Combi 40 cochlear implant.

Acta Otolaryngol 118:640-645, 1998
Impact factor: 0,812

41. Bredberg G, Linström B, Löppönen H, Beltrame M.A., Gstoettner W, Skarzynski H A new approach for the treatment of ossified cochleas

Central and East Europ Journal of ORL, Head and Neck Surg. Vol 3, 2/10: 264 – 267, 1998

42. Gstoettner W, Franz P, Hamzavi J, Plenk H, Baumgartner W, Czerny C Intracochlear Position of Cochlear Implant Electrodes

Acta Otolaryngol 119:229-33, 1999
Impact factor: 0,812

43. Temmel A, Kierner A, Muhm M, Gstoettner W Reversible sensoneurinal hearing impairment induced by a carotid body tumor

Europ Arch Otorhinolaryngol 256:466-9, 1999
Impact factor: 0,646

44. Gstoettner W, Matula C, Hamzavi J, Kornfehl J, Czerny Ch, Temmel A, Güler N, Novak K Long term results of different treatment modalities in 37 patients with glomus jugulare tumors

Europ Arch Otorhinolaryngol 256:351-5, 1999
Impact factor: 0,646

45. Anton J V, Gstoettner W, Matula Ch Interdisziplinäres Management bei der Behandlung von Tumoren der vorderen Schädelgrube

Wien Klin Wochenschr 2;112:473-6, 1999
Impact factor: 0,646

46. Gstoettner W, Baumgartner W, Hamzavi J Hörrehabilitation mit Cochlear Implantaten

Pädiatrie und Pädologie 2:12-17, 1999

47. Muhm M, Polterauer P, Gstoettner W, Temmel A, et al. Glomus caroticum – Chemodectom. Übersicht über die aktuelle Diagnostik und Therapie.

Wien Klin Wochenschr 112:115-120, 2000
Impact factor: 0,646

48. Hamzavi J, Deutsch W, Baumgartner WD, Denk DM, Adunka O, Gstoettner W Cochlear implantation and auditory feedback

Wien Klin Wochenschr 2;112:515-8, 2000
Impact factor: 0,646

49. Baumgartner WD, Youssefzadeh S, Czerny C, Hamzavi J, Adunka O, Gstoettner W Clinical Utilization of magnetic resonance imaging for patients with cochlear implants

Wien Klin Wochenschr 2;112:512-4, 2000
Impact factor: 0,646

50. Czerny C, Gstoettner W, Adunka O, Hamzavi J, Baumgartner WD Postoperative imaging and evaluation of the electrode position and depth of insertion of multichannel cochlear implants by means of high-resolution computed tomography and conventional X-rays

Wien Klin Wochenschr 2;112:509-11, 2000
Impact factor: 0,646

51. Baumgartner WD, Gstoettner W, Hamzavi J, Adunka O, Czerny C Preoperative diagnostic procedures before cochlear implantation

Wien Klin Wochenschr 2;112:505-8, 2000
Impact factor: 0,646

52. Hamzavi J, Adunka O, Baumgartner WD, Gstoettner W Speech discrimination in noise for patients with cochlear implants

Wien Klin Wochenschr 2;112:498-504, 2000
Impact factor: 0,646

53. Baumgartner WD, Youssefzadeh S, Czerny C, Franz P, Hamzavi J, Gstoettner W, Clinical application of magnetic resonance imaging in cochlear-implanted patients

Adv Otorhinolaryngol 57:28-31, 2000

54. Gstoettner W, Hamzavi J, Baumgartner WD, Egelierler B, Adunka O Hearing and speech discrimination scores of prelingually deaf children with cochlear implants

Wien Klin Wochenschr 2;112:492-7, 2000
Impact factor: 0,646

55. Gstoettner W, Adunka O, Hamzavi J, Lautischer M, Baumgartner WD Speech discrimination in post-lingually deaf patients with cochlear implants

Wien Klin Wochenschr 2;112:487-91, 2000
Impact factor: 0,646

56. Czerny C, Gstoettner W, Adunka O, Hamzavi J, Baumgartner WD Preoperative imaging of the inner ear prior to the implantation of a multichannel cochlear implant using computed and MR technology

Wien Klin Wochenschr 2;112:481-6, 2000
Impact factor: 0,646

57. Gstoettner W, Hamzavi J, Franz P, Plenk H Jr, Czerny C, Susani M, Adunka O, Baumgartner WD Intracochleäre Position von Cochlea Implant Elektroden

Wien Klin Wochenschr 2;112:477-80, 2000
Impact factor: 0,646

58. Gstoettner W, Baumgartner WD, Hamzavi J, Adunka O Cochlear implantation--the Viennese surgical technique

Wien Klin Wochenschr 2;112:473-6, 2000
Impact factor: 0,646

59. Gstoettner W, Adunka O, Hamzavi J, Baumgartner WD Rehabilitation of hearing-impaired patients with cochlear implants: a review

Wien Klin Wochenschr 2;112:464-72, 2000
Impact factor: 0,646

60. Gstoettner W Cochlear implants in children and adults

Wien Klin Wochenschr 2;112:463, 2000
Impact factor: 0,646

61. Anton J V, Schultze J, Gstoettner W, Matula Ch Tumors of the anteriorskull base. Effects of perioperative imaging on adjuvant radiotherapy planning

Roentgenpraxis 53(1):10-5, 2000

62. Gstoettner WK, Hamzavi J, Baumgartner WD, Czerny CC Fixation of the electrode array with bone pate in cochlear implant surgery.

Acta Otolaryngol 120:369-74, 2000
Impact factor: 0,812

63. Hamzavi J, Deutsch W, Baumgartner WD, Bigenzahn W, Gstoettner W Short-term effect of auditory feedback on fundamental frequency after cochlear implantation.

Audiology. 39:102-5, 2000
Impact factor: 1,293

64. Jolly CN, Gstoettner W, Hochmair-Desoyer I, Baumgartner WD, Hamzavi J Principles and outcome in periomodiolar positioning.

Ann Otol Rhinol Laryngol, Dez;185:20-3, 2000
Impact factor: 0,954

65. Hamzavi J, Baumgartner WD, Egelierler B, Franz P, Schenk B, Gstoettner W Follow up of cochlear implanted handicapped children.

Int J Pediatr Otorhinolaryngol 22;56:169-74, 2000
Impact factor: 0,529

66. Gstoettner WK, Hamzavi J, Egelierler B, Baumgartner WD Speech perception performance in prelingually deaf children with cochlear implants.

Acta Otolaryngol 120:209-13, 2000
Impact factor: 0,812

67. Hamzavi JS, Baumgartner WD, Adunka O, Franz P, Gstoettner W Audiological performance with cochlear reimplantation from analogue single-channel implants to digital multi-channel devices.

Audiology 39:305-10, 2000
Impact factor: 1,293

68. Gstoettner WK, Hamzavi J, Baumgartner WD Speech discrimination scores of postlingually deaf adults implanted with the Combi 40 cochlear implant.

Adv Otorhinolaryngol 57:323-6, 2000

69. Hamzavi J, Baumgartner WD, Gstoettner W Hearing performance of cochlear implant patients in noise.

Adv Otorhinolaryngol 57:320-2, 2000

70. Kiefer J, Hohl S, Stuerzebecher E, Pfennigdorff T, Gstoettner W Comparison of speech recognition with different speech coding strategies (SPEAK, CIS, and ACE) and their relationship to telemetric measures of compound action potentials in the nucleus CI 24M cochlear implant system.

Audiology 40:32-42, 2001
Impact factor: 1,293

71. Hamzavi J, Franz P, Baumgartner WD, Gstoettner W Hearing performance in noise of cochlear implant patients versus severely-profoundly hearing-impaired patients with hearing aids.

Audiology 40:26-31, 2001
Impact factor: 1,293

72. Kierner AC, Zelenka I, Gstoettner W The sternocleidomastoid flap: its indications and limitations.

Laryngoscope 111:2201-4, 2001
Impact factor: 1,457

73. Czerny C, Gstoettner W, Franz P, Baumgartner WD, Imhof H CT and MR imaging of acquired abnormalities of the inner ear and cerebellopontine angle.

Eur J Radiol 40:105-12, 2001

74. Baumgartner WD, Youssefzadeh S, Hamzavi J, Czerny C, Gstoettner W Clinical application of magnetic resonance imaging in 30 cochlear implant patients.

Otol Neurotol 22:818-22, 2001
Impact factor: 1,073

75. Gstoettner WK, Adunka O, Franz P, Hamzavi J, Plenk H Jr, Susani M, Baumgartner W, Kiefer J Perimodiolar electrodes in cochlear implant surgery.

Acta Otolaryngol 121:216-9, 2001
Impact factor: 0,812

76. Kierner AC, Burian M, Bentzien S, Gstoettner W Intraoperative electromyography for identification of the trapezius muscle innervation: clinical proof of a new anatomical concept.

Laryngoscope 112:1853-6, 2002
Impact factor: 1,457

77. Baumgartner WD, Pok SM, Egelierler B, Franz P, Gstoettner W, Hamzavi J The role of age in pediatric cochlear implantation.

Int J Pediatr Otorhinolaryngol 62:223-8, 2002
Impact factor: 0,529

78. Arnold W, Bredberg G, Gstoettner W, Helms J, Hildmann H, Kiratzidis T, Mueller J, Ramsden RT, Roland P, Walterspiel JN Meningitis following cochlear implantation: pathomechanisms, clinical symptoms, conservative and surgical treatments.

ORL J Otorhinolaryngol Relat Spec. 64:382-9, 2002
Impact factor: 0,734

79. Saringer W, Kitz K, Czerny C, Kornfehl J, Gstoettner W, Matula C, Knosp E Paragangliomas of the Temporal Bone: Results of Different Treatment Modalities in 53 Patients

Acta Neurochir 144: 1255-1264, 2002
Impact factor: 0,957

80. Bredberg G, Lindström B, Baumgartner W, Farhadi M, Goldberg T, Ceenta Ch, Gstoettner W et al Open set speech perception in adult cochlear implant useres with ossified cochleae

Cochlear Implants International, 4(2) 55-72, 2003

81. Czerny C, Gstoettner W, Imhof H Computed tomography and magnetic resonance imaging of congenital abnormalities of the temporal bone

Radiologe 43(3) 227-33, 2003
Impact factor: 0,621

82. Grampp S, Czerny C, Henk C B, Gstoettner W, Imhof H Computed tomography and magnetic resonance imaging of acquired abnormalities of the inner ear and cerebello-pontine angle

Radiologe 43(3) 213-8, 2003
Impact factor: 0,621

83. Hamzavi J, Baumgartner W D, Pok S M, Franz P Gstoettner W Variables affecting speech perception in postlingually deaf adults following cochlear implantation

Acta Otolaryngol 123(4):493-8, 2003
Impact factor: 0,812

84. Imhof H, Henk C B, Dirisamer A, Czerny C, Gstoettner W CT and MRI characteristics of toumors of the temporal bone and the cerebello-pontine angle

Radiologe 43(3) 219-26, 2003
Impact factor: 0,621

85. Krestan C, Czerny C, Gstoettner W, Franz P The role of high-resolution computed tomography (HRCT) and magnetic resonance imaging (MTI) in the diagnosis of preoperative and postoperative complications caused by acquired cholesteatomas

Radiologe 43(3) 207-12, 2003
Impact factor: 0,621

86. Vogl TJ, Schick C, Mack M, Gstoettner W Diagnostic imaging and differential diagnosis of pathological processes of the sinus cavernosus

Radiologe 43(2) 161-70, 2003
Impact factor: 0,621

87. Knecht R, Peters S, Adunka O, Strebhardt K, Gstoettner W, Hambek M Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents.

Anticancer Res 23:2577-83, 2003
Impact factor: 1,416

88. Adunka O, Gstoettner W, Knecht R, Kierner AC Expression of hypoxia inducible factor 1 alpha and Von Hippel Lindau protein in human middle ear cholesteatoma.

Laryngoscope 113:1210-5, 2003
Impact factor: 1,457

89. Adunka O, Moustaklis E, Weber A, May A, von Ilberg C, Gstoettner W, Kierner AC Labyrinth anesthesia: a forgotten but practical treatment option in Meniere's disease.

ORL J Otorhinolaryngol Relat Spec 65:84-90, 2003
Impact factor: 0,734

90. Hamzavi J, Baumgartner WD, Pok SM, Franz P, Gstoettner W Variables affecting speech perception in postlingually deaf adults following cochlear implantation.

Acta Otolaryngol 123:493-8, 2003
Impact factor: 0,812

91. Kiefer J, Gstoettner W, Baumgartner W, Pok S, Tillein J, Qing Ye, Ilberg C Conservation of Low-frequency Hearing in Cochlear Implantation.

Acta Otolaryngol 123:1-10, 2003
Impact factor: 0,812

92. Knecht R, Peters S, Hambek M, Solbach C, Baghi M, Gstoettner W EGFR-antibody-supplemented TPF chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment.

Anticancer Res 23:4789-96, 2003
Impact factor: 1,416

93. May A, Lehne C, Lambrecht E, Enzensberger R, Brade V, Gstoettner W, Weber A Prospektive pathomorphologische, immunologische und mykologische Untersuchungen zur chronischen Pilzsinusitis

Allergologie, Jahrgang 27, Nr.3, 95-101, 2004
Impact factor: 0,557

94. Adunka O, Gstoettner W, Hambek M, Unkelbach MH, Radeloff A, Kiefer J Preservation of basal inner ear structures in cochlear implantation

ORL J Otorhinolaryngol Relat Spec 66:306-12, 2004
Impact factor: 0,734

95. Adunka O, Kiefer J, Unkelbach MH, Radeloff A, Lehnert T, Gstoettner W Evaluation of an electrode design for the combined electric acoustic stimulation

Laryngorhinootologie 83:653-8, 2004

96. Adunka O, Kiefer J, Unkelbach MH, Pok SM, Gstoettner W Evaluating cochlear implant trauma to the scala vestibuli

Clin Otolaryngol 29:1-6, 2004
Impact factor: 0,665

97. Adunka O, Unkelbach MH, Mack M, Hambek M, Gstoettner W, Kiefer J Cochlear Implantation via the round window membrane minimizes trauma to cochlear structures – a histologically controlled insertion study

Acta ORL 124:807-12, 2004
Impact factor: 0,812

98. Adunka O, Kiefer J, Unkelbach MH, Lehnert T, Gstoettner W Development and evaluation of an improved cochlear implant electrode design for electric acoustic stimulation

Laryngoscope 114:1237-41, 2004
Impact factor: 1,457

99. Gstoettner W, Kiefer J, Baumgartner WD, Pok S, Peters S, Adunka O Hearing Preservation in Cochlear Implantation for Electric Acoustic Stimulation

Acta Otolaryngol 124:348-52, 2004
Impact factor: 0,812

100. Hambek M, Baghi M, Strebhard K, May A, Adunka O, Gstoettner W, Knecht R STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR

Anticancer Res 24:3881-6. 2004
Impact factor: 1,416

101. Kiefer J, Gstoettner W, Baumgartner W, Pok SM, Tillein J, Ye Q, von Ilberg C Conservation of low-frequency hearing in cochlear implantation

Acta Otolaryngol 124:272-80, 2004
Impact factor: 0,812

102. Kiefer J, Tillein J, Ye Q, Klinke R, Gstoettner W Application of carbon dioxide and erbium:yttrium-aluminum-garnet lasers in inner ear surgery: an experimental study

Otol Neurotol 25:400-9, 2004
Impact factor: 1,073

103. Hamzavi J, Pok S, Gstoettner W, Baumgartner W Speech perception with a cochlear implant used in conjunction with a hearing aid in the opposite ear

International Journal of Audiology 43:1-5, 2004
Impact factor: 0,635

104. Peters S, Hambek M, Gstoettner W, Knecht R Wertigkeit von Tissue-Microarrays in Immunhistochemischen proliferationsassoiziierten Reihenuntersuchungen von Kopf-Hals-Karzinomen

HNO 2004 52:409-412, 2004
Impact factor: 0,722

105. Arnoldner C, Baumgartner W, Gstoettner W, Egelierler B, Czerny C, Steiner E, Hamzavi J Audiological performance after cochlear implantation in children with inner ear malformations

Int J Pediatr Otorhinolaryngol 68:457-467, 2004
Impact factor: 0,528

106. Adunka O, Unkelbach M C, Gstoettner W, Hambek M, Knecht R Ein klinisch-wissenschaftliches Datenbanksystem zur Erfassung und Auswertung onkologischer Daten im Kopf-Halsbereich

HNO, 53(1) 39-45, 2005
Impact factor: 0,722

107. Arnoldner C, Baumgartner WD, Gstoettner W, Hamzavi J Surgical considerations in cochlear implantation in children and adults: a review of 342 cases in Vienna

Acta Otolaryngol 125(3):228-34, 2005
Impact factor: 0,812

108. Knecht R, Peters S, Hambek M, Solbach C, Baghi M, Gstoettner W EGFR-antibody-supplemented TPF chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment.

Adv Otorhinolaryngol 62:81-91, 2005

109. Adunka O, Kiefer J, Unkelbach MH, Radeloff A, Gstoettner W Evaluating cochlear implant trauma to the scala vestibule

Clin Otolaryngol 30(2):121-7, 2005
Impact factor: 0,665

110. Adunka O, Unkelbach MH, Mack MG, Radeloff A, Gstoettner W Predicting basal cochlear length for electric-acoustic stimulation

Arch Otolaryngol Head Neck Surg 131(6):488-92, 2005
Impact factor: 1,242

111. Hey C, Rose MA, Kujumdshiev S, Gstoettner W, Schubert R, Zielen S Does the 23-valent pneumococcal vaccine protects cochlear implant recipients?

Laryngoscope 115(9):1586-90, 2005
Impact factor: 1,457

112. Hambek M, Baghi M, Baumann H, Strebhard K, Adunka O, Gstoettner W, Knecht R Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN)

Anticancer Res (3B):1871-5, 2005
Impact factor: 1,416

113. Kiefer J, Pok M, Adunka O, Stuerzebecher E, Baumgartner W, Schmidt M, Tillein J, Ye Q, Gstoettner W Combined electric and acoustic stimulation of the auditory system: results of a clinical study

Audiol Neuro-otol 10(3):134-44, 2005
Impact factor: 2,532

114. Gstoettner W, Pok SM, Peters S, Kiefer J, Adunka O Cochlear implantation with preservation of residual deep frequency hearing

HNO 53(9):784-90, 2005
Impact factor: 0,722

115. Baghi M, Mack MG, Hambek M, Rieger J, Vogl T, Gstoettner W, Knecht R The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers

Anticancer Res 25(5):3665-70, 2005
Impact factor: 1,416

116. Aladwan A, Mack M, Gstoettner W, Vogl TJ Duplication of internal carotid artery: a rare case of tympanic mass

Eur Radiol. 15(12):2525-7, 2005
Impact factor: 1,969

117. Hambek M, Baghi M, Strebhard K, Baumann H, Gstoettner W, Knecht R Reduction of cisplatin dosage by ZD 1839

Anticancer Res. 25(6B):3985-8, 2005
Impact factor: 1,416

118. Gstoettner W, Unkelbach M Die ipsilaterale elektrisch-akustische Stimulation

Wien Klin Wochenschr 9:12-13, 2005
Impact factor: 0,646

119. Baghi M, Hambek M, May A, Radeloff A, Gstoettner W, Knecht R Adjuvant Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.

Anticancer Res. 26:559-564, 2006
Impact factor: 1,416

120. Baghi M., Hambek M, Wagenblast J, May A, Gstoettner W, Knecht R A Phase II Trial of Docetaxel, Cisplatin and 5-Fluorouracil in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Anticancer Res. 26:585-590, 2006
Impact factor: 1,416

121. Hambek M, Adunka O, Baghi M, Gstoettner W, Knecht R AdOnco: A Database for Clinical and Scientific Documentation of Head and Neck Oncology

Annals of Otology, Rhinology & Laryngology 115(2):144-149, 2006
Impact factor:0,954

122. Czerny C, Nemec M, Krestan C, Gstoettner W Benign and malignant lesions in the region of the inner ear and cerebellopontine angle

Radiologe.Mar;46(3):197-204, 2006
Impact factor:0,621

123. Hambek M, Werner C, Baghi M, Gstoettner W, Knecht R Prestimulation of head and neck cancer cells with growth factors enhances treatment efficacy

Anticancer Res Mar-Apr;26(2A):1091-5, 2006
Impact factor: 1,416

124. Gstoettner W, Maier N, Helbig S, Kiefer J, Radeloff A, Adunka O Ipsilateral Electric Acoustic Stimulation of the Auditory System: Long-Term Preservation of Acoustic Hearing

Audiol Neuro-Otol 11:49-56, 2006
Impact factor: 2,532

125. Bisdas S, Baghi M, Abdelkader A, Gstoettner W, Fetscher S, Vogl T Primary B-Cell Lymphoma of the Central Skull Base

Clin Neuroradiol 16:258-61, 2006

126. Helbig M, Helbig S, Knecht R, Kahla-Witzsch HA, Gstoettner W Qualitätsmanagement nach DIN EN ISO 9001:2000

HNO Dez, 54(12):922-8, 2006
Impact factor: 0,722

127. Helbig M, Helbig S, Knecht R, Kahla-Witzsch HA, Gstoettner W Quality management: Reduced waiting time and enhanced efficiency in a university ear, nose and throat outpatient department

HNO 55(1):29-35,2007
Impact factor: 0,571

128. Hambek M, Werner C, Baghi M, Gstoettner W, Knecht R Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation

Eur J Cancer 43(10)1502-7, 2007
Impact factor: 4,454

129. Baghi M, Mack M, Hambek M, Bisdas S, Muerthel R, Wagenblast J, Gstoettner W, Knecht R Usefulness of MRI volumetric evaluation in patients with SCCHN treated with neoadjuvant chemotherapy

Head Neck J SCI SPEC Feb, 29(2):104-8,2007
Impact factor: 2,007

130. Kiefer J, Ye Q, Tillein J, Adunka O, Arnold W, Gstoettner W Protecting the Cochlea during Stapes Surgery: Is There a Role for Corticosteroids?

Adv Otorhinolaryngol 65:300-7, 2007

131. Bisdas S, Baghi M, Huebner F, Mueller C, Knecht R, Vorbucher M, Gstoettner W, Vogl T In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neck

Eur Radiol 17(1):251-7, 2007
Impact factor: 3,405

132. Radeloff A, Unkelbach M, Tillein J, Braun S, Helbig S, Gstoettner W, Adunka O Impact of Intrascalar Blood on Hearing

Laryngoscope 117(1):58-62, 2007
Impact factor: 1,801

133. Ye Q, Tillein J, Hartmann R, Gstoettner W, Kiefer J Application of a Corticosteroid (Triamcinolon) Protects Inner Ear Function after Surgical Intervention

Ear Hear, 28:361-97, 2007
Impact factor: 2,057

134. Baumgartner, WD, Jappel A, Morea C, Gstoettner W, Müller J, Kiefer J, Anderson I, Nielsen S Outcomes in adults implanted with the FLEXsoft electrode

Acta Otolaryngol, 127(6)579-86, 2007
Impact factor: 0,983

135. Baghi M, Mack M, Wagenblast J, Hambek M, Rieger J, Bisdas S, Gstoettner W, Engels K, Vogl T, Strebhardt K, Knecht R Iron oxide particle enhanced Magnetic Resonance Imaging for detection of benign lymph nodes in head and neck, how reliable are the results?

Anticancer Reasearch 27:3571-5, 2007
Impact factor: 1,414

136. Baghi M, Wagenblast J, Hambek M, Radeloff A, Gstoettner W, Scherzed A, Spaenkuch B, Yuan J, Hornung S, Strebhardt K, Knecht R Demands of the caring relatives in head and neck cancer patients.

Laryngoscope 117(4):712-6, 2007
Impact factor: 1,801

137. Adunka OF, Radeloff A, Gstoettner WK, Pillsbury HC, Buchman CA Scala tympani cochleostomy II: topography and histology.

Laryngoscope 117:2195-2007
Impact factor: 1,801

138. Bisdas S, Fetscher S, Feller AC, Baghi M, Knecht R, Gstoettner W, Vogl TJ, Balzer JO Primary B cell lymphoma of the sphenoid sinus: CT and MR characteristics with correlation to perfusion and spectroscopic imaging features.

Eur. Arch ORL 264 (10):1207-13, 2007
Impact factor: 0,648

139. Baghi M, Wagenblast J, Hambek M, Moertel S, Gstoettner W, Spaenkuch B, Yuan J, Strebhardt K, Knecht R Pretreatment haemoglobin level predicts remission rate and survival after TPF-induction polychemotherapy in advanced head and neck cancer patients

Clin ORL, 33:245-51, 2008
Impact factor: 1,477

140. Helbig M, Krysztoforski K, Kucharski J, Popek M, Kroll T, Helbig S, May A, Gstoettner W, Kozak J Navigation-assisted sonography for soft tissues in the head and neck region.

HNO 20081011, Medline 2008
Impact factor: 0,653

141. Unkelbach MH, Radeloff A, Bink A, Gstoettner W, Ziemann U Megadolichobasilar analomaly causing acute deafness with vertigo.

HNO, 56 (1), 62-4, 2008
Impact factor: 0,653

142. Wagenblast J, Baghi M, Arnoldner C, Bisdas S, Gstoettner W, Ackermann H, Hambek M, May A Craniofacial reconstruction with bone-anchored epithesis in head and neck cancer patients – a valid way back to self-perception and social reintegration

Anticancer research, 28:2349-52, 2008
Impact factor: 1,414

143. Wagenblast J, Baghi M, Helbig M, Arnoldner C, Bisdas S, Gstoettner W, May A, Knecht R, Hambek M Effect of bortezomib and cetuximab in EGF-stimulated HNSCC.

Anticancer research, 28:2239-43, 2008
Impact factor: 1,414

144. Helbig S, Baumann U, Helbig M, von Mahlsen-Waldkirch N, Gstoettner W A new combined speech processor for electric and acoustic stimulation – eight months experience.

ORL J Otorhinolaryngol Relat Spec 70:359-65, 2008
Impact factor: 0,757

145. Wagenblast J, Baghi M, Arnoldner C, Bisdas S, Gstoettner W, May A, Knecht R, Hambek M Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificity.

Oncol Rep 20:1207-11, 2008
Impact factor: 1.597

146. Arnoldner C, Riss D, Kaider A, Mair A, Wagenblast J, Baumgartner WD, Gstoettner W, Hamzavi JS The Intensity-pitch relation revisited: monopolar versus bipolar cochlear stimulation

Laryngoscope 118:1630-6, 2008
Impact factor: 1,801

147. Gstoettner W, Arnoldner C Re: Reimplantation of hybrid cochlear implant users with a full-lenght electrode after loss of residual hearing

Otol Neurotol 29:881-2, 2008
Impact factor: 1,410

148. Radeloff A, Mack M, Baghi M, Gstoettner WK, Adunka OF Variance of angular insertion depths in free-fitting and perimodiolar cochlear implant electrodes.

Otol Neurotol 29:131-6, 2008
Impact factor: 1,410

149. Gstoettner W, Van de Heyning P, O Connor F, Morea C, Anderson I Electric acoustic stimulation of the auditory system: Results from multicenter EAS clinical investigation.

Acta Otolaryngol, 128:968-75, 2008
Impact factor: 0,983

150. Helbig M, Krysztoforski K, Krowicki P, Helbig S, Gstoettner W, Kozak J Development of prototype for navigated real-time sonography for the head and neck region

Head Neck J SCI SPEC 30:215-21, 2008
Impact factor: 2,007

151. Wagenblast J, Hambek M, Baghi M, Gstoettner W, Strebhardt K, Ackermann H, Knecht R Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines

Anticancer Res, 134:323-30, 2008
Impact factor: 1,414

152. Helbig M, Krysztoforski K, Kroll T, Kucharski J, Popek M, Helbig S, Gstoettner W, May A, Kozak J Navigation-supported and sonographically-controlled fine-needle puncture in soft tissues of the neck.

Ultrasound Med Biol 35 (3); p. 436-42, 2009
Impact factor:1,922

153. Gstoettner W, Helbig S, Settevendemie C, Baumann U, Wagenblast J, Arnoldner C A new electrode for residual hearing preservation in cochlear implantation: first clinical results

Acta Otolaryngol, 127(6)579-86, 2009
Impact factor: 0,983

154. Wagenblast J, Baghi M, Arnoldner C, Bisdas S, Gstoettner W, Ackermann H, Hambek M, Knecht R Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines.

J. Cancer Res. Clin. Oncol 135(3)387-93, 2009
Impact factor: 2,366